Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/24/2018
Draft Amendment of the Drug Administration Law under Review by the NPC
10/24/2018
CANbridge and WuXi Biologics Enter into Rare Disease Partnership
10/23/2018
IQVIA: Chinese Retail Pharmacy Market Surged 3.9% in MAT Q2/2018
10/23/2018
Healthcare Sector Growth Slows in First Three Quarters of 2018
10/23/2018
China Is Funding the Future of American Biotech
10/23/2018
China Electronics Data and WuXi AppTec Form Healthcare Big Data JV
10/18/2018
Chi-Med Starts Phase I Study of HMPL-523 for Leukemia In China
10/18/2018
Recent Executive Moves
10/18/2018
IQVIA: Chinese Hospital Drug Market Up 2.8% in MAT Q2/2018
10/18/2018
NHC Drafts Plan to Boost Overall Clinical Appraisal of Drug Products
10/17/2018
Eisai's NDA for Antiepileptic Perampanel Accepted in China
10/16/2018
DiaMedica and Fosun Subsidiary Signs License Agreement for Stroke Medi...
10/16/2018
Alphamab's HER2 Bispecific Antibody KN026 Gains US IND
10/16/2018
CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001
10/15/2018
How to Fulfill China’s Potential for Carrying Out Clinical Trials
10/15/2018
Innovent Granted Chinese IND for Sintilimab/Bevacizumab Combinaiton Th...
10/15/2018
Zheijiang Huahai Placed under Increased Supervision
10/15/2018
Exploring Ways to Establish Presence in China as Part of APAC Region P...
10/12/2018
Eisai's NDA for Antiepileptic Drug Perampanel Accepted in China
10/12/2018
Mesoblast and Tasly Complete Strategic Cardiovascular Partnership in C...
10/11/2018
NEJM and CCA Enter Partnership for CVS Research and Training
10/11/2018
MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...
10/10/2018
SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...
10/9/2018
Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...
10/9/2018
Listed Chinese Pharma Cos Reports Positive Performance in H1
10/8/2018
CDE Solicits Comments on Technical Requirements for Manufacturing Site...
10/8/2018
NMPA Issues Rules for Communications Related to Drug R&D and Techn...
10/8/2018
Biosimilars and Healthcare Policy: What China Can Learn from the EU an...
10/8/2018
Amyris Enters into Extensive Partnership with Yifan Pharma
10/8/2018
Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs
Page:
158
/
361
Total number of articles:
10826
:
[First]
[<<]
[156]
[157]
[158]
[159]
[160]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit